| Mr Charles E Hufstetler, AA | |
|
501 Redmond Rd Nw, Rome, GA 30165-1415 | |
| (706) 291-0291 | |
| Not Available |
| Full Name | Mr Charles E Hufstetler |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology Assistant |
| Experience | 16 Years |
| Location | 501 Redmond Rd Nw, Rome, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518111624 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367H00000X | Anesthesiologist Assistant | 005384 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Floyd Medical Center | Rome, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Georgia Group Services, Llc | 0840338018 | 66 |
| Redmond Anesthesia And Pain Treatment, Pc | 4880841741 | 41 |
News Archive
Every week reporter Ankita Rao selects interesting reading from around the Web.
If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
A new study has shown that the introduction of smoke-free legislation has not led to an increase in children's exposure to secondhand smoke in their own homes.
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
› Verified 9 days ago
| Entity Name | Georgia Group Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093947236 PECOS PAC ID: 0840338018 Enrollment ID: O20091109000203 |
News Archive
Every week reporter Ankita Rao selects interesting reading from around the Web.
If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
A new study has shown that the introduction of smoke-free legislation has not led to an increase in children's exposure to secondhand smoke in their own homes.
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
› Verified 9 days ago
| Entity Name | Redmond Anesthesia And Pain Treatment, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821350984 PECOS PAC ID: 4880841741 Enrollment ID: O20120828000499 |
News Archive
Every week reporter Ankita Rao selects interesting reading from around the Web.
If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
A new study has shown that the introduction of smoke-free legislation has not led to an increase in children's exposure to secondhand smoke in their own homes.
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Charles E Hufstetler, AA 501 Redmond Rd Nw, Rome, GA 30165-1415 Ph: (706) 291-0291 | Mr Charles E Hufstetler, AA 501 Redmond Rd Nw, Rome, GA 30165-1415 Ph: (706) 291-0291 |
News Archive
Every week reporter Ankita Rao selects interesting reading from around the Web.
If you're balding and want your hair to grow back, then here is some good news. A new research report appearing online in The FASEB Journal shows how the FDA-approved glaucoma drug, bimatoprost, causes human hair to regrow.
ZyStor Therapeutics, Inc., a biotechnology company developing a new class of targeted protein therapeutics for the treatment of Lysosomal Storage Diseases using the Company's proprietary Glycosylation Independent Lysosomal Targeting technology, today announced that it has received clearance from the U. S. Food and Drug Administration to proceed into a clinical trial for its first drug candidate, ZC-701, an enzyme replacement therapy for the treatment of Pompe disease.
A new study has shown that the introduction of smoke-free legislation has not led to an increase in children's exposure to secondhand smoke in their own homes.
Newborns are highly vulnerable to infections and don't respond optimally to most vaccines because their young immune systems typically mount weak antibody responses.
› Verified 9 days ago
Douglas E Mcniece, PA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 501 Redmond Rd Nw, Anesthesiology Department, Rome, GA 30165 Phone: 706-291-0291 | |
Jeffrey Lee Mahoney, PA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 501 Redmond Rd Nw, Rome, GA 30165 Phone: 706-291-0291 | |
Stephen Mark Walker, PAAA Anesthesiologist Assistant Medicare: Not Enrolled in Medicare Practice Location: 330 Turner Mccall Blvd Sw, Rome, GA 30165 Phone: 706-802-2000 Fax: 706-233-9846 | |
Mr. Harry Mallette Peagler Iv, AA Anesthesiologist Assistant Medicare: Accepting Medicare Assignments Practice Location: 304 Turner Mccall Blvd Sw, Rome, GA 30165 Phone: 706-509-5000 | |
Mr. Billy Don Deberry Iii, Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 304 Turner Mccall Blvd Sw, Rome, GA 30165 Phone: 706-509-5000 | |
Magdalene Jo Magee, PA Anesthesiologist Assistant Medicare: Medicare Enrolled Practice Location: 501 Redmond Rd Nw, Anesthesiology Department, Rome, GA 30165 Phone: 706-368-8022 Fax: 706-368-8452 |